Contract 75D30123D16646
Moderna Us, Inc. · Department Of Health And Human Services · July 11, 2024
Moderna Us, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on July 11, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 9, 2025. If all options are exercised, the contract could reach $408.05 million.
Contract details
- PIID
- 75D30123D16646
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- July 11, 2024
- Latest action
- July 9, 2025
Description
ADULT COVID-19 VACCINES
Modification timeline
-
July 9, 2025Mod P00010 · Other Administrative Action$50.50M
-
January 15, 2025Mod P00009$-16.83M
-
July 11, 2024Mod P00008 · Other Administrative Action$67.33M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30123D16646?
Contract 75D30123D16646 is a federal contract awarded to Moderna Us, Inc. by Department Of Health And Human Services on July 11, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75D30123D16646?
Moderna Us, Inc. won contract 75D30123D16646 from Department Of Health And Human Services.
How much is contract 75D30123D16646 worth?
Contract 75D30123D16646 has obligated $0 to date but carries a potential ceiling of $408.05 million if fully funded and all options are exercised.